Crowdfunding A Patent-Free Drug For Treating Cancer

from the here's-how-it's-done dept

Here on Techdirt we've been pretty scathing about the way that Big Pharma develops drugs -- often poorly -- and then uses patent monopolies to keep prices so high that only rich Westerners can afford them. Of course, it's easy to complain about the flaws of the current approach, but are there any alternatives? We've already covered one -- using prizes - and now Carl Levinson points us to another potentially powerful approach: crowdsourcing. It's already been adopted by 'Project Marilyn' to develop a patent-free anti-cancer drug:

The campaign will fund a xenograft experiment, which is the next step in developing the promising anti-cancer compound "9DS". This experiment needs to be completed before 9DS can move on to clinical trials.
Here are some more details of both the drug and the project:
The drug candidate 9DS was developed at the University of Maryland. The last work done on the drug showed that it had activity against cancer competitive with leading cancer drugs such as taxol. Moreover, 9DS is also likely to have lower side effects than most chemotherapies, since a related compound, SJG-136, seems to have low side effects in early clinical trials.

Project Marilyn involves: production of more 9DS, and submitting 9DS to a xenograft study ('curing cancer in mice'). This is the next step in drug development and an important one on the way to doing clinical (human) studies. The process we're seeking to fund should take approximately 6 months. If we receive more funding, we will add stretch goals, such as further preclinical experiments on 9DS, development 9DS analogs, or other exciting anti-cancer ideas.
Of course, even if enough money is raised -- at the time of writing, just over a quarter of the crowdfunding target has been pledged -- there's still much more work to be done before the drug can be sold to the public. An article in the Times of San Diego explains what will happen next:
Provided that the xenograft study goes well, 9DS will move into further preclinical trials, possibly through a collaboration with a for-profit company. Research and development at the later stages costs between $1 million and $10 million and will likely not be crowdfunded.

Due the drug's patent status, the threat of competition is likely to keep the price of 9DS low, regardless of a partnership with a for-profit company. Currently, when a drug loses its patent status, the price can come down ten-fold, according to [project leader Dr. Isaac] Yonemoto.
It's only a small-scale project, but it's exciting to see new funding models being tried out for drug development. Moreover, the Times of San Diego reports that Yonemoto wants his site to host further crowdfunded projects, both from himself and other researchers. Let's hope enough pledges are made, and that others do indeed start to build on the idea.

Follow me @glynmoody on Twitter or, and +glynmoody on Google+

Reader Comments

Subscribe: RSS

View by: Time | Thread

  • icon
    Ninja (profile), 30 Sep 2014 @ 3:31am

    Holy crap we need more of these. Donated a few bucks.

    Now that's something I'm more than willing to throw my money at. As a side teaser, that's where part of the money file sharing saves me (by not buying crap) goes. You see, file sharing is saving lives!


    reply to this | link to this | view in chronology ]

  • identicon
    Anonymous Coward, 30 Sep 2014 @ 4:02am

    We need more publicly funded non-patented drugs, it is an absolute travesty that there exists companies in this world that make billions out of exploiting sick people.

    reply to this | link to this | view in chronology ]

  • identicon
    Anonymous Coward, 30 Sep 2014 @ 9:25am

    What is stopping them from turning back on their words and just patenting whatever they create from the funds they get?

    I would love to believe they are honest and mean what they say, but is there anything in place to keep them honest and not submit to greed.

    reply to this | link to this | view in chronology ]

    • identicon
      Brian, 10 Mar 2015 @ 11:17am


      What stops them from patenting it is that it is a drug that is not patentable because it has either been out for a while for another purpose and no longer has a patent for that or is a natural compound found in nature and therefore not patentable. You can only patent new synthesized compounds.

      reply to this | link to this | view in chronology ]

  • icon
    sigalrm (profile), 30 Sep 2014 @ 9:34am

    I wish them luck....

    but as someone who's involved on the IT and GRC side of a 501(c)3 that's working on genetic research, $50k for this bit of research seems way too low when you take into account real-world (well, US-based) costs associated with this type of research.

    Reality says that the regulatory environment in the US is pay to play. It sucks, but good intentions and wishful thinking won't get you into the dollar amounts required to play for very long.

    reply to this | link to this | view in chronology ]

  • icon
    Whatever (profile), 30 Sep 2014 @ 5:56pm

    It's a wonderful idea, a great concept, but likely only playing right into the hands of big Pharma.

    The big expense of such production and testing isn't the mice phase, it's all the other testing (including human testing) which can take years, pushing through all of the FDA approval process, and finally getting it available to those who might benefit from it. Oh, let's not forget the risk related to having the drug somehow fail after it hits the market and people start suing left and right. Do you think everyone involved in crowdfunding it might be on the hook? ;)

    Seriously though, something does need to be done to move the medical world forward. The current approval process and itchy trigger finger lawsuit universe makes it pretty undesirable to produce anything these days.

    reply to this | link to this | view in chronology ]

  • identicon
    DarrkPhoenix, 30 Sep 2014 @ 7:09pm

    Commendable approach, horrible compound

    Disclosure: I work in the pharmaceutical industry (medicinal chemistry- one of the guys in the lab designing and making molecules).

    While I wish these guys the best of luck, they're not making things easy on themselves with their choice of compound. I had a quick look through the data in the linked paper, and in the best case scenarios LC50s against cancer cell lines were only in the 50-100 nM range, while against the vast majority of cell lines tested the compound didn't even register a hit. For reference, we usually try to find compounds that have activity in the sub nM range before even progressing them into animal models (in other words compounds that are over 100 times more potent than this one).

    The compound also exhibits cardiotox at concentrations in the same range as the best case LC50s, and that's just in vitro (once you go in vivo you generally discover plenty of additional tox, you almost never see things improve). Based on this alone I wouldn't expect this compound to be able to get past preclinical safety assessment (a key FDA requirement before compounds can be tested in humans).

    Also, to provide a bit more information on the assay they're raising money for, a mouse xenograft model is a fairly early-stage assay, and also a pretty low bar (it's one you still need to pass, but there's a long, long road after that). They'd likely need another $1,000,000+ to get enough of a preclinical package together to take to the FDA or to try to partner (and even those numbers are probably being a bit generous). Even though that's ultimately just a rounding error compared to the costs of clinical trials, it's still a fair amount to spend on a compound that's already looking as poor as this one just in in vitro assays.

    So while I fully support alternative models for the development of pharmaceuticals and wish these guys the best of luck, I have a feeling they're going to be getting quite a lesson in the numerous pitfalls of drug development.

    reply to this | link to this | view in chronology ]

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here
Get Techdirt’s Daily Email
Use markdown for basic formatting. HTML is no longer supported.
  Save me a cookie
Follow Techdirt
Insider Shop - Show Your Support!

Report this ad  |  Hide Techdirt ads
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Report this ad  |  Hide Techdirt ads
Recent Stories
Report this ad  |  Hide Techdirt ads


Email This

This feature is only available to registered users. Register or sign in to use it.